Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022;23(11):882-896.
doi: 10.2174/1389200223666220803103039.

Nanoparticle-Based Inhalation Therapy for Pulmonary Diseases

Dhananjay Yadav  1 , Peninah M Wairagu  2 , Minseok Kwak  3 , Jun-O Jin  4
Affiliations

Nanoparticle-Based Inhalation Therapy for Pulmonary Diseases

Dhananjay Yadav et al. Curr Drug Metab. 2022.

Abstract

The lung is exposed to various pollutants and is the primary site for the onset of various diseases, including infections, allergies, and cancers. One possible treatment approach for such pulmonary diseases involves direct administration of therapeutics to the lung so as to maintain the topical concentration of the drug. Particles with nanoscale diameters tend to reach the pulmonary region. Nanoparticles (NPs) have garnered significant interest for applications in biomedical and pharmaceutical industries because of their unique physicochemical properties and biological activities. In this article, we describe the biological and pharmacological activities of NPs as well as summarize their potential in the formulation of drugs employed to treat pulmonary diseases. Recent advances in the use of NPs in inhalation chemotherapy for the treatment of lung diseases have also been highlighted.

Keywords: Natural polymer; biomedical applications; lung therapy; nanoparticle; phagocytosis; respiratory disease.

PubMed Disclaimer

References

    1. Ventola C.L.; Progress in nanomedicine: Approved and investigational nanodrugs. P - PubMed
    1. Lu Y.; Sun W.; Gu Z.; Stimuli-responsive nanomaterials for therapeutic protein delivery. J Control Release 2014,194,1-19 - DOI - PubMed
    1. Navya P.N.; Daima H.K.; Rational engineering of physicochemical properties of nanomaterials for biomedical applications with nanotoxi-cological perspectives. Nano Converg 2016,3(1),1-14 - DOI - PubMed
    1. Khan I.; Saeed K.; Khan I.; Nanoparticles: Properties, applications and toxicities. Arab J Chem 2019,12,908-931 - DOI
    1. Babu A.; Templeton A. K.; Munshi A.; Ramesh R.; Nanoparticlebased drug delivery for therapy of lung cancer: Progress and challenges. J Nanomater 2013,2013 - DOI

Substances